GlassScriptPhysician profile
Brenda Schiesel
NPI 1346476579
$2,031.02
in general payments reported to CMS, 2019-2025
11 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $571 · 2021: $297 · 2022: $274 · 2023: $52.25 · 2024: $88.39 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,204.01 | 2019-2022 | |
| Abbvie INC. | $293.06 | 2024-2025 | |
| Allergan, INC. | $188.60 | 2020-2022 | |
| Mentor Worldwide LLC | $114.26 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $74.10 | 2025 | |
| Integra Lifesciences Corporation | $50.72 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Galderma Laboratories, L.P. | $35.09 | 2020-2025 | |
| Revance Therapeutics, INC. | $22.48 | 2025 | Daxxify |
| Heron Therapeutics, INC. | $20.20 | 2025 | Aponvie |
| Ethicon US, LLC | $18.59 | 2022 | |
| Apyx Medical Corporation | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Schiesel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.